Impact of Calcified Nodules on Clinical Outcomes in Hemodialysis Patients Undergoing Percutaneous Coronary

Tatsuo Yokomine1, Takashi Kajiya2, Tatsuro Takei2

  • 1Department of Cardiology, Tenyoukai Central Hospital, Kagoshima, Japan; Department of Cardiovascular Medicine and Hypertension, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan.

Insights

Calcified nodules (CNs) significantly increase major adverse cardiovascular events (MACE) and cardiovascular death risk in hemodialysis patients undergoing percutaneous coronary intervention (PCI). These findings highlight the critical need for careful management of CNs in this high-risk population.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Nephrology

Background:

  • Calcified nodules (CNs) are linked to poor outcomes post-percutaneous coronary intervention (PCI).
  • CNs occur more frequently in hemodialysis patients, a population with increased cardiovascular risk.
  • The specific prognosis of CNs in hemodialysis patients undergoing PCI remains under-investigated.

Purpose of the Study:

  • To investigate the 1-year prognosis of hemodialysis patients with CNs who underwent PCI.
  • To compare the incidence of major adverse cardiovascular events (MACE) between patients with and without CNs.

Main Methods:

  • Retrospective analysis of 141 hemodialysis patients undergoing PCI between January 2020 and December 2021.
  • Intravascular ultrasound (IVUS) and/or optical coherence tomography (OCT)/optical frequency domain imaging (OFDI) used for diagnosis.
  • MACE (cardiovascular death, target lesion myocardial infarction, target lesion revascularization) was the primary endpoint.

Main Results:

  • Patients with CNs showed a significantly higher incidence of MACE at 1 year (39.2% vs 9.9%, p <0.001).
  • Cardiovascular death rates were also significantly higher in the CNs group (17.7% vs 4.2%, p = 0.009).
  • CNs were independently associated with an increased risk of MACE (adjusted hazard ratio: 4.93, p <0.001).

Conclusions:

  • Calcified nodules are associated with a substantially higher risk of MACE in hemodialysis patients undergoing PCI.
  • The presence of CNs independently predicts adverse cardiovascular outcomes, including increased cardiovascular mortality, in this patient cohort.

Related Concept Videos

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
976
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
3.4K
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
450
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
500
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
2.2K
Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this...
1.8K